# TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck

> **NCT03729518** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 150 (estimated)

## Conditions studied

- Oropharyngeal Cancer
- Squamous Cell Carcinoma
- Human Papilloma Virus

## Interventions

- **RADIATION:** Radiation Therapy (IMRT or IMPT)

## Key facts

- **NCT ID:** NCT03729518
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-10-11
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03729518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03729518, "TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT03729518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*